The Independent Voice of
European Private Equity

Advanced Search

Mercia Fund backs Native Antigen spin-out

jamesharris@realdeals.dev.caspianmedia.com 16 February 2011

Native Antigen Company (NAC), a developer of bacteria purification technology, has spun out from PsiOxus with backing from the Mercia Fund.

Related Articles

VC performance hits new high

23/07/19

Waterland-backed Median makes two deals

23/07/19

LBO France makes investment in Ecritel

23/07/19

Agilitas-backed Hydro makes second bolt-on

23/07/19

Innova Capital buys Optiplaza

23/07/19

Maven invests in computing company ebb3

23/07/19